About moroctocog alfa
Recombinant factor VIII clotting factor
Used for
- Treatment and prevention of bleeding in haemophilia A
- Control of bleeding during surgery in haemophilia A
Usual adult dose
Dose is individualized by body weight, desired factor VIII level, and bleeding severity; commonly 20–50 IU/kg per dose.
Usual dose in children
Dose is individualized by body weight, desired factor VIII level, and bleeding severity; commonly 20–50 IU/kg per dose.
Common side effects
- Headache
- Fever
- Nausea
- Development of factor VIII inhibitors
Important warnings
- Factor VIII inhibitors can reduce or stop treatment response.
- Severe allergic reactions, including anaphylaxis, can occur.
- Seek urgent assessment for signs of a blood clot.
- Use only by intravenous injection as prescribed.
Pregnancy
Limited pregnancy data; use only when clearly needed and under specialist care.
Breastfeeding
It is unknown whether this medicine passes into breast milk; use requires clinical assessment.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.